Catalyst Funds Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,000
Closed -$46.8K 1249
2024
Q1
$46.8K Buy
+1,000
New +$46.8K 0.01% 578